nav emailalert searchbtn searchbox tablepage yinyongbenwen piczone journalimg journalInfo journalinfonormal searchdiv searchzone qikanlogo popupnotification paper paperNew
2022, 12, v.41;No.422 1292-1295
苓甘五味姜辛汤合止嗽散治疗青年寒饮蕴肺型慢性咳嗽临床研究
基金项目(Foundation): 海南省卫生计生行业科研项目(编号:18A200090
邮箱(Email):
DOI: 10.16295/j.cnki.0257-358x.2022.12.008
摘要:

目的:观察苓甘五味姜辛汤合止嗽散治疗青年寒饮蕴肺型慢性咳嗽的临床疗效。方法:选取寒饮蕴肺型慢性咳嗽青年患者86例,按随机数字表法分为治疗组与对照组各43例。治疗组采用苓甘五味姜辛汤合止嗽散治疗,对照组采用西医常规治疗,两组均治疗1个月。比较两组临床疗效、症状评分、不良反应发生率及1年复发率。结果:治疗组、对照组总有效率分别为90.70%、72.09%,两组临床疗效比较,差异有统计学意义(P<0.05)。两组治疗后咳嗽、痰量、神疲乏力、胸闷气促评分较治疗前均降低,且治疗组上述各项症状评分均低于对照组,差异有统计学意义(P<0.05)。治疗组不良反应发生率和1年复发率均低于对照组,差异有统计学意义(P<0.05)。结论:与常规西医治疗相比,苓甘五味姜辛汤合止嗽散治疗青年寒饮蕴肺型慢性咳嗽疗效较好,改善症状效果较明显,不良反应发生率及复发率较低。

Abstract:

Objective:To study the clinical curative efficacy of Linggan Wuwei Jiangxin Decoction(苓甘五味姜辛汤) combined with Zhisou Powder(止嗽散) in the treatment of young patients with chronic cough with syndrome of cold fluid retention in lung. Methods:A total of 86 young patients with chronic cough with syndrome of cold fluid retention in lung were divided into treatment group and control group by random number table method,with 43 cases in each group. The treatment group was treated with Linggan Wuwei Jiangxin Decoction combined with Zhisou Powder,while the control group was treated with conventional western medicine. Both the two groups were treated for 1 month. The clinical curative efficacy,symptom scores,incidence of adverse reactions,and one-year recurrence rate of the two groups were compared.Results:The total effective rate of the treatment group was 90.70% and that of the control group was 72.09%. The difference of clinical curative efficacy between the two groups was statistically significant(P<0.05). After treatment,in both the two groups,the symptom scores of cough,sputum amount,mental fatigue and lack of strength,and chest tightness and shortness of breath were lower than those before treatment,and the above scores of the treatment group were lower than those of the control group(P<0.05). The incidence of adverse reactions and one-year recurrence rate of the treatment group were lower than those of the control group(P<0.05). Conclusions:Compared with conventional western medicine,Linggan Wuwei Jiangxin Decoction combined with Zhisou Powder has better curative efficacy in treating young patients with chronic cough with syndrome of cold fluid retention in lung. It is more effective in relieving symptoms,and can reduce the incidence of adverse reactions and recurrence rate.

参考文献

[1]中华医学会呼吸病学分会哮喘学组.咳嗽的诊断与治疗指南(2015)[J].中华结核和呼吸杂志,2016,39(5):323-354.

[2]黄金华,许浦生,黎教武,等. X线胸片无明显异常的慢性咳嗽流行病学调查[J].广东医学,2017,38(10):1574-1577.

[3]周琼,骆天炯.感染后咳嗽发病机制的研究进展[J].中华肺部疾病杂志(电子版),2018,11(3):373-376.

[4]国家中医药管理局.中医病证诊断疗效标准:ZY/T001.1~001.9-94[S].南京:南京大学出版社,1994:2.

[5]郑筱萸.中药新药临床研究指导原则(试行)[M].北京:中国医药科技出版社,2002:53-66.

[6]万学红,卢雪峰.诊断学[M].北京:人民卫生出版社,2018:16.

[7]林彬,史利卿,马建岭,等.慢性咳嗽伏邪病机认识探讨[J].现代中医临床,2017,24(5):12-15.

[8]白逸晨,史利卿,季坤,等.慢性咳嗽肺脾相关病机探讨[J].现代中医临床,2018,25(4):48-51.

[9]彭伟.苓甘五味姜辛汤合止嗽散加减治疗慢性咳嗽临床效果及安全性评价[J].中国社区医师,2018,34(21):98-99.

基本信息:

DOI:10.16295/j.cnki.0257-358x.2022.12.008

中图分类号:R256.11

引用信息:

[1]周明萍,吕佳杰,冯超,等.苓甘五味姜辛汤合止嗽散治疗青年寒饮蕴肺型慢性咳嗽临床研究[J],2022,41(12):1292-1295.DOI:10.16295/j.cnki.0257-358x.2022.12.008.

基金信息:

海南省卫生计生行业科研项目(编号:18A200090

检 索 高级检索